Dariten (Enablex)7.5 Mg – 30 tablet

Dariten (Enablex)7.5 Mg – 30 tablet

$30.78

Each Dariten contains 7.5 mg Darifenacin 30 tablets per box. Dariten is used for the treatment of an overactive bladder in adults.

ATC Classification: G04BD10
Active Ingrediant: Darifenacin
Generic Name: Dariten OD
Manufacturer: Ranbaxy Limited
Strength: 7.5 Mg
Dosage Type: Tablet
Packaging Type: Foil in Box
Contains: 30 Tabs

Description

Darifenacin Information


What is this drug used for?

• It is used to treat an overactive bladder.

 

Possible side effects

Darifenacin may cause side effects. Tell your doctor if any of these symptoms are severe or do not go away:

• Heartburn.
• Constipation.
• Dry mouth.
• Upset stomach.
• Headache.

Some side effects can be serious. If you experience any of these symptoms, call your doctor immediately or get emergency medical treatment:

• Signs of an allergic reaction, like rash; hives; itching; red, swollen, blistered, or peeling skin with or without fever; wheezing; tightness in the chest or throat; trouble breathing, swallowing, or talking; unusual hoarseness; or swelling of the mouth, face, lips, tongue, or throat.
• Signs of a urinary tract infection (UTI) like blood in the urine, burning or pain when passing urine, feeling the need to pass urine often or right away, fever, lower stomach pain, or pelvic pain.
• Very bad headache.
• Feeling confused.
• Hallucinations (seeing or hearing things that are not there).
• Feeling sleepy.
• Very bad constipation.
• Very bad belly pain.
• Trouble passing urine.
• Change in eyesight.
• Not sweating during activities or in warm temperatures.
• Dizziness or passing out.
• Fever.
• Feeling tired or weak.
• Very upset stomach or throwing up.

 

Medication Safety Issues

Sound-alike/look-alike issues:

Enablex may be confused with Effexor XR

Geriatric Patients: High-Risk Medication:

Beers Criteria: Darifenacin is identified in the Beers Criteria as a potentially inappropriate medication in patients 65 years and older due to its strong anticholinergic properties (Beers Criteria [AGS 2019]).

 

Storage and Stability

Store at 25°C (77°F); excursions permitted to 15°C to 30°C (59°F to 86°F). Protect from light.

 

Adverse Reactions

>10%: Gastrointestinal: Xerostomia (19% to 35%), constipation (15% to 21%)

1% to 10%:

Cardiovascular: Hypertension (≥1%), peripheral edema (≥1%)

Central nervous system: Headache (7%), dizziness (<2%), pain (≥1%)

Dermatological: Pruritus (≥1%), skin rash (≥1%), xeroderma (≥1%)

Endocrine & metabolic: Weight gain (≥1%)

Gastrointestinal: Dyspepsia (3% to 8%), abdominal pain (2% to 4%), nausea (2% to 4%), vomiting (≥1%)

Genitourinary: Urinary tract infection (4% to 5%), vaginitis (≥1%), urinary retention (acute)

Neuromuscular & skeletal: Weakness (<3%), arthralgia (≥1%), back pain (≥1%)

Ophthalmic: Dry eye syndrome (2%), visual disturbance (≥1%)

Respiratory: Flu-like symptoms (1% to 3%), bronchitis (≥1%), pharyngitis (≥1%), rhinitis (≥1%), sinusitis (≥1%)

Postmarketing and/or case reports: Anaphylaxis, angioedema, confusion, erythema multiforme, granuloma (annulare), hallucination, hypersensitivity reaction, palpitations

Brand

Ranbaxy

Additional information

Active Ingrediant

Generic Name

Alternate Names

, , , , , , , , , , , ,

Strength

Dosage Type

Packaging Type

Reviews

There are no reviews yet.

Be the first to review “Dariten (Enablex)7.5 Mg – 30 tablet”

Your email address will not be published.